Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2026-02-27 @ 10:34 AM
Study NCT ID:
NCT02151851
Status:
COMPLETED
Last Update Posted:
2018-06-28
First Post:
2014-05-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Certolizumab Pegol as Additional Therapy in Chinese Patients With Active Rheumatoid Arthritis
Sponsor:
UCB Pharma SA, Belgium
Organization: